URS – A PROSPECTIVE INTERNATIONAL OBSERVATIONAL STUDY ON INDICATIONS AND PERIOPERATIVE OUTCOMES.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24272

Enrollment

5000

Registered

2009-11-18

Start date

2010-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteroscopy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion of data on all patients undergoing ureteroscopy.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Secondary

Measure	Time frame
1. To assess the peri-operative morbidity (30 days), including SAE, and translate them in the Clavien score; 2. To define risk factors for the development of peri-operative morbidity after URS.	—

Primary

Measure	Time frame
To assess the current indications for URS and the treatment outcomes in terms of the stone free rate.	—

Contacts

Public ContactSonja Rees Vellinga, van

info@croesoffice.org+31 (0)20 56 66377

Outcome results